Skip to main content
SpringerLink
Log in

Particle therapy for cancers: a new weapon in radiation therapy

  • Review
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

Particle irradiation started to draw attention in the past decade and has now become a hotspot in the radiation oncology community. This article reviews the most advanced developments in particle irradiation, focusing on the characteristics of proton and carbon ions in radiation physics and radiobiology. The Bragg peak of physical dose distribution causes proton and carbon beams to optimally meet the requirement for cancer irradiation because the Bragg peak permits the accurate concentration of the dose on the tumor, thus sparing the adjacent normal tissues. Moreover, carbon ion has more radiobiological benefits than photon and proton beams. These benefits include stronger sterilization effects on intrinsic radio-resistant tumors and more effective killing of hypoxic, G0, and S phase cells. Compared with the most advanced radiation techniques using photon, such as three-dimensional conformal radiation therapy and intensity-modulated radiation therapy, proton therapy has yielded more promising outcomes in local control and survival for head and neck cancers, prostate carcinoma, and pediatric cancers. Carbon therapy in Japan showed even more promising results than proton therapy. The local controls and overall survivals were as good as that treated by surgery in early stages of non-small cell lung cancer, hepatocellular carcinoma, prostate carcinoma, and head and neck cancers, especially for such highly resistant tumors as melanoma. The non-invasive nature of particle therapy affords more patients with chances to receive and benefit from treatment. Particle therapy is gradually getting attention from the oncology community. However, the cost of particle therapy facilities has limited the worldwide use of this technology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Slater JM, Archambeau JO, Miller DW, Notarus MI, Preston W, Slater JD. The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development. Int J Radiat Oncol Biol Phys 1992; 22(2): 383–389

    Article  PubMed  CAS  Google Scholar 

  2. Tsujii T, Kamada T, Baba M, Tsuji H, Kato H, Kato S, Yamada S, Yasuda S, Yanagi T, Kato H, Hara R, Yamamoto N, Mizoe J. Hirotoshi Kato, Shingo Kato, Shigeru Yamada, Shigeo Yasuda, Yanagi T, Kato H, Hara R, Yamamoto N, Mizoe J. Clinical advantages of carbon-ion radiotherapy. N J Phys 2008; 10(7): 075009

    Article  Google Scholar 

  3. Suit HD, Chu W. History of charged particle radiotherapy. In: DeLaney TF, Kooy HM. Proton and Charged Particle Radiotherapy. Wolter Kluwer, Lippincoot Williams and Wilkins, 2008: 1–7

    Google Scholar 

  4. Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 2006; 65(4): 1087–1096

    Article  PubMed  Google Scholar 

  5. Gerwech L, Paganetti H. Radiobiology of charged particles. In: DeLaney TF, Kooy HM. Proton and Charged Particle Radiotherapy. Wolter Kluwer, Lippincoot Williams and Wilkins, 2008: 8–17

  6. Fokas E, Kraft G, An H, Engenhart-Cabillic R. Ion beam radiobiology and cancer: time to update ourselves. Biochimica et Biophysica Acta 2009;1796: 216–229

    PubMed  CAS  Google Scholar 

  7. Allen C, Borak TB, Tsujii H, Nickoloff JA. Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy. Mutat Res 2011; 711(1–2): 150–157

    PubMed  CAS  Google Scholar 

  8. Joiner MC. Linear energy transfer and relative biological effectiveness. In: Joiner M, van der Kogel A. Basic clinical radiobiology. 4th ed. Hodder Arnold, 2009:168–177

  9. Bush DA, Slater JD, Shin BB, Cheek G, Miller DW, Slater JM. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 2004; 126(4): 1198–1203

    Article  PubMed  Google Scholar 

  10. Nihei K, Ogino T, Ishikura S, Nishimura H. High-dose proton beam therapy for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006; 65(1): 107–111

    Article  PubMed  Google Scholar 

  11. Iwata H, Murakami M, Demizu Y, Miyawaki D, Terashima K, Niwa Y, Mima M, Akagi T, Hishikawa Y, Shibamoto Y. High-dose proton therapy and carbon-ion therapy for stage I non-small cell lung cancer. Cancer 2010; 116(10): 2476–2485

    PubMed  Google Scholar 

  12. Nakayama H, Satoh H, Sugahara S, Kurishima K, Tsuboi K, Sakurai H, Ishikawa S, Tokuuye K. Proton beam therapy of Stage II and III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81(4):979–984

    Article  PubMed  Google Scholar 

  13. Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, Allen PK, Lu C, Gillin M, Cox JD. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for non-small cell lung cancer. Cancer 2011; 117(13): 3004–3013

    Article  PubMed  Google Scholar 

  14. Slater JD, Yonemoto LT, Rossi CJ Jr, Reyes-Molyneux NJ, Bush DA, Antoine JE, Loredo LN, Schulte RW, Teichman SL, Slater JM. Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 1998; 42(2): 299–304

    Article  PubMed  CAS  Google Scholar 

  15. Slater JD, Rossi CJ Jr, Yonemoto LT, Bush DA, Jabola BR, Levy RP, Grove RI, Preston W, Slater JM. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 2004; 59(2): 348–352

    Article  PubMed  Google Scholar 

  16. Igaki H, Tokuuye K, Okumura T, Sugahara S, Kagei K, Hata M, Ohara K, Hashimoto T, Tsuboi K, Takano S, Matsumura A, Akine Y. Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 2004; 60(4): 1120–1126

    Article  PubMed  Google Scholar 

  17. Kawashima M, Furuse J, Nishio T, Konishi M, Ishii H, Kinoshita T, Nagase M, Nihei K, Ogino T. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 2005; 23(9): 1839–1846

    Article  PubMed  Google Scholar 

  18. Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chuganji Y, Kagei K, Shoda J, Hata M, Abei M, Igaki H, Tanaka N, Akine Y. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 2005; 11(10): 3799–3805

    Article  PubMed  Google Scholar 

  19. Carr BI, Nagalla S. Medical therapy for HCC. In: Carr BI. Hepatocellular Carcinoma. 2ed. New York: Humana Press, 2009: 551–554

    Google Scholar 

  20. Proceedings of Int Sym Heavy Ion Therapy. Jan 8–9, 2011, Tokyo, Japan

  21. Gorenstein LA, Sonett JR. The surgical management of stage I and stage II lung cancer. Surg Oncol Clin N Am 2011; 20(4): 701–720

    Article  PubMed  Google Scholar 

  22. Miyamoto T, Baba M, Yamamoto N, Koto M, Sugawara T, Yashiro T, Kadono K, Ezawa H, Tsujii H, Mizoe JE, Yoshikawa K, Kandatsu S, Fujisawa T; Working Group for Lung Cancer. Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 2007; 67(3): 750–758

    Article  PubMed  CAS  Google Scholar 

  23. Miyamoto T, Baba M, Sugane T, Nakajima M, Yashiro T, Kagei K, Hirasawa N, Sugawara T, Yamamoto N, Koto M, Ezawa H, Kadono K, Tsujii H, Mizoe JE, Yoshikawa K, Kandatsu S, Fujisawa T; Working Group for Lung Cancer. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2007; 2(10): 916–926

    Article  PubMed  Google Scholar 

  24. Earl TM, Chapman WC. Conventional surgical treatment of hepatocellular carcinoma. Clin Liver Dis 2011; 15(2): 353–370, vii–x

    Article  PubMed  Google Scholar 

  25. Kato H, Tsujii H, Miyamoto T, Mizoe JE, Kamada T, Tsuji H, Yamada S, Kandatsu S, Yoshikawa K, Obata T, Ezawa H, Morita S, Tomizawa M, Morimoto N, Fujita J, Ohto M; Liver CancerWorking Group. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 2004; 59(5): 1468–1476

    Article  PubMed  Google Scholar 

  26. Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji H, Kato H, Kato S, Yamada S, Yasuda S, Ohno T, Yanagi T, Imai R, Kagei K, Hara R, Hasegawa A, Nakajima M, Sugane N, Tamaki N, Takagi R, Kandatsu S, Yoshikawa K, Kishimoto R, Miyamoto T. Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res (Tokyo) 2007; 48(Suppl A):A1–A13

    Article  CAS  Google Scholar 

  27. Mizoe JE, Tsujii H, Kamada T, Matsuoka Y, Tsuji H, Osaka Y, Hasegawa A, Yamamoto N, Ebihara S, Konno A. Dose escalation study of carbon ion radiotherapy for locally advanced head-andneck cancer. Int J Radiat Oncol Biol Phys 2004; 60(2): 358–364

    Article  PubMed  Google Scholar 

  28. Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jäkel O, Edler L, Scholz M, Debus J. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 2007; 68(2): 449–457

    Article  PubMed  Google Scholar 

  29. Imai R, Kamada T, Tsuji H, Yanagi T, Baba M, Miyamoto T, Kato S, Kandatsu S, Mizoe JE, Tsujii H, Tatezaki S. Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 2004; 10(17): 5741–5746

    Article  PubMed  CAS  Google Scholar 

  30. Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe JE, Miyamoto T, Kato H, Yamada S, Morita S, Yoshikawa K, Kandatsu S, Tateishi A. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002; 20(22): 4466–4471

    Article  PubMed  CAS  Google Scholar 

  31. Brada M, Pijls-Johannesma M, De Ruysscher D. Current clinical evidence for proton therapy. Cancer J 2009; 15(4): 319–324

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China

    Guo-Liang Jiang

Authors
  1. Guo-Liang Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guo-Liang Jiang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, GL. Particle therapy for cancers: a new weapon in radiation therapy. Front. Med. 6, 165–172 (2012). https://doi.org/10.1007/s11684-012-0196-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-012-0196-4

Keywords

Search

Navigation